GlobeNewswire EN Nachrichten :: Artikel

27.04.26 - 08:06	Transaction in Own Shares (GlobeNewswire EN)
	OSB GROUP PLCISIN: GB00BLDRH36027 April 2026...

27.04.26 - 08:03	Garrett Motion′s Breakthrough Oil-Free Centrifugal Compressor Enhances High-Efficiency Liquid Cooling Solutions (GlobeNewswire EN)
	Powering TONFY's next-generation battery energy storage (BESS) liquid cooling systems Powering TONFY's next-generation battery energy storage (BESS) liquid cooling systems...

27.04.26 - 08:03	Aspo Plc′s Interim Report, January 1 – March 31, 2026: Stable performance in a challenging operating environment (GlobeNewswire EN)
	Aspo Q1 Interim Report...

27.04.26 - 08:03	NBPE Announces Audited Annual Financial Report and 31 March 2026 monthly NAV (GlobeNewswire EN)
	...

27.04.26 - 08:03	Rob Shuter resigns from KPN′s Supervisory Board (GlobeNewswire EN)
	Today, KPN announces that Mr. Rob Shuter has resigned from the Supervisory Board, in light of his other commitments....

27.04.26 - 08:03	ASM announces resignation of Supervisory Board member Mr Van den Brink (GlobeNewswire EN)
	Almere, The NetherlandsApril 27, 2026, 8:00 a.m. CET...

27.04.26 - 08:03

Pulsar Helium Awards Security Based Compensation (GlobeNewswire EN)

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS....

27.04.26 - 08:03	NBPE Announces Transaction in Own Shares (GlobeNewswire EN)
	THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS...

27.04.26 - 08:03	Casino Group Communication (GlobeNewswire EN)
	Casino Group Communication...

27.04.26 - 07:57	WeRide and Lenovo Collaborate to Deploy 200,000 Autonomous Vehicles Globally Over Five Years (GlobeNewswire EN)
	WeRide and Lenovo collaborated at Auto China 2026 to deploy 200,000 autonomous vehicles globally over the next five years....

27.04.26 - 07:33	Exosens delivers strong Q1 2026 performance, with accelerating defense momentum in digital imaging and night vision; Fully on track to deliver on 2026 guidance (GlobeNewswire EN)
	EXOSENS DELIVERS STRONG Q1 2026 PERFORMANCE, WITH ACCELERATING DEFENSE MOMENTUMIN DIGITAL IMAGING AND NIGHT VISION...

27.04.26 - 07:33	FORVIA to Sell its Interiors Business Group to Apollo Funds (GlobeNewswire EN)
	FORVIA to Sell its Interiors Business Group to Apollo Funds...

27.04.26 - 07:33	FORVIA: CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS OF FORVIA SUBJECT TO APPROVAL BY THE 2026 ANNUAL GENERAL MEETING (GlobeNewswire EN)
	PRESSRELEASE...

27.04.26 - 07:33	Apollo Funds to Acquire Forvia′s Automotive Interiors Business (GlobeNewswire EN)
	Transaction to Establish Leading Global Automotive Interiors Supplier as Standalone Company Transaction to Establish Leading Global Automotive Interiors Supplier as Standalone Company...

27.04.26 - 07:33	OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients (GlobeNewswire EN)
	OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant...

27.04.26 - 07:18

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria (GlobeNewswire EN)

Basel, April 27, 2026 – Novartis announced today that the European Commission (EC) approved Rhapsido® (remibrutinib) for chronic spontaneous urticaria (CSU) in adult patients with inadequate response to H1-antihistamine treatment. Rhapsido is the first oral targeted treatment approved for CSU, offering a unique approach to CSU treatment in a pill taken twice daily without any lab monitoring required1....

27.04.26 - 07:03

Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU (GlobeNewswire EN)

Pratteln, Switzerland, April 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending an extension to the marketing authorization for AGAMREE® (vamorolone) to include the treatment of patients with Duchenne muscular dystrophy (DMD) from 2 years of age....

27.04.26 - 07:03	Biotalys Achieves First U.S. State Registration for EVOCA in Florida (GlobeNewswire EN)
	Biotalys' innovative biofungicide EVOCA™ has achieved state registration in Florida. This marks the first approval of an AGROBODY™ biocontrol by a US state...

27.04.26 - 07:03	Aktsiaselts Infortar own share acquisition transactions (GlobeNewswire EN)
	Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 20 April – 24 April 2026 as follows:...

27.04.26 - 07:03	Kitron: Ex dividend NOK 0.70 today (GlobeNewswire EN)
	The shares in Kitron ASA will be traded ex dividend NOK 0.70 as from today, 27.04.2026....

>weitere News anzeigen...